Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

N Engl J Med. 2022 Mar 10;386(10):998-999. doi: 10.1056/NEJMc2116999. Epub 2022 Jan 26.

Authors

Affiliations

¹ Hadassah Medical Center, Jerusalem, Israel mevorachd@gmail.com.
² Israeli Ministry of Health, Jerusalem, Israel.
³ Shaare Zedek Medical Center, Jerusalem, Israel.
⁴ Israel Center for Disease Control, Ramat Gan, Israel.
⁵ Hadassah Medical Center, Jerusalem, Israel.
⁶ University of Haifa, Haifa, Israel.
⁷ Israeli Ministry of Health, Jerusalem, Israel sharon.alroy@moh.gov.il.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
BNT162 Vaccine / adverse effects*
Child
Female
Hospitalization / statistics & numerical data*
Humans
Immunization, Secondary / adverse effects*
Incidence
Israel / epidemiology
Male
Myocarditis / chemically induced
Myocarditis / epidemiology*
Risk
Sex Distribution

Substances

BNT162 Vaccine